Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe

BACKGROUND: Real-world studies of the burden of severe haemophilia B in the context of recent therapeutic advances such as extended half-life (EHL) factor IX (FIX) products are limited. We analysed data from the recent CHESS II study to better understand the clinical, humanistic, and economic burden...

Descripción completa

Detalles Bibliográficos
Autores principales: Burke, Tom, Asghar, Sohaib, O’Hara, Jamie, Chuang, Margaret, Sawyer, Eileen K., Li, Nanxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691083/
https://www.ncbi.nlm.nih.gov/pubmed/34930388
http://dx.doi.org/10.1186/s13023-021-02152-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691083/
https://www.ncbi.nlm.nih.gov/pubmed/34930388
http://dx.doi.org/10.1186/s13023-021-02152-1

Ejemplares similares